Association between chronotypes and comorbidities in obstructive sleep apnea: The age effect.
N, A., V, V., AI, K., P, G., P, S., & G, T. (2026). Association between chronotypes and comorbidities in obstructive sleep apnea: The age effect.. Pulmonology. https://doi.org/10.1080/25310429.2026.2679351
N A, V V, AI K, P G, P S, G T. Association between chronotypes and comorbidities in obstructive sleep apnea: The age effect.. Pulmonology. 2026; doi: 10.1080/25310429.2026.2679351
N A, V V, AI K, et al. Association between chronotypes and comorbidities in obstructive sleep apnea: The age effect.[J]. Pulmonology. 2026. DOI: 10.1080/25310429.2026.2679351.
@article{n2026,
author = {Athanasiou N and Vlachakos V and Karapiperi AI and Galanis P and Steiropoulos P and Trakada G},
title = {Association between chronotypes and comorbidities in obstructive sleep apnea: The age effect.},
journal = {Pulmonology},
year = {2026},
doi = {10.1080/25310429.2026.2679351},
note = {PMID: 42210759},
}
TY - JOUR AU - Athanasiou N AU - Vlachakos V AU - Karapiperi AI AU - Galanis P AU - Steiropoulos P AU - Trakada G TI - Association between chronotypes and comorbidities in obstructive sleep apnea: The age effect. T2 - Pulmonology PY - 2026 DO - 10.1080/25310429.2026.2679351 AN - PMID:42210759 ER -
BACKGROUND: Obstructive sleep apnoea (OSA) is associated with increased cardiometabolic risk. Although a chronotype, a phenotypic marker of circadian rhythm, appears to influence this relationship, the influence of age-related differences has not been fully elucidated. This study aims to evaluate chronotypes and their association with age in identifying comorbidity risk among patients with OSA. METHODS: In this cross-sectional study of 671 adults from three outpatient sleep clinics (median age 56, interquartile range 47-65; 60.2% men) had a medical history assessment, completed standardised questionnaires, and underwent in-lab polysomnography or home sleep testing. An individual's chronotype was assessed using the Morningness - Eveningness Questionnaire (MEQ), whereas comorbidities were determined based on patients' medical history and/or pharmacological treatment. Multivariable analysis was performed to adjust for potential confounders. RESULTS: The morning chronotype is associated with a higher prevalence of arterial hypertension, dyslipidemia, diabetes mellitus, and cardiovascular disease compared with evening chronotype (all p < 0.05), particularly among participants younger than 60 years. In contrast, depression was more frequently observed among individuals with an evening chronotype, with no significant age-related effect. CONCLUSION: In newly diagnosed patients with OSA, the morning chronotype was primarily associated with cardiometabolic comorbidities, especially in young and middle-aged adults, but not in older individuals, suggesting that it may represent a potential adjunctive clinical marker.